Sipping hope or hype?
| Sunday, May 4, 2025 |
| 2:00 PM - 2:20 PM |
| Grand Ballroom |
Overview
Dr Andrew Stafford
Details
Competency standards Souvenaid® is a supplement that contains a combination of nutrients that are thought to slow the progression of mild cognitive impairment and early Alzheimer’s disease. However, there is limited evidence of its effects, and it is not without financial cost. This presentation will review the evidence relating to Souvenaid to assist credentialed pharmacists to contribute to shared decision-making about its use.
Learning objectives:
- Describe the studies that have investigate the effects of Souvenaid® and the outcomes experienced by patients who used it
- Assist Discuss patients with decision-making about the use of Souvenaid® with patients
Competency standards : 1.6, 3.5
Speaker
Dr Andrew Stafford
Senior Lecturer, Curtin Medical School
Curtin University, Perth
Sipping hope or hype?
Biography
Andrew is an academic and an accredited pharmacist with an interest in optimising medicine use in older people. His experience in aged care has spanned the residential and community sectors, and he currently provides medication reviews and QUM services for a number of providers in Western Australia. Andrew’s research interests include the development and assessment of programs that aim to optimise healthcare for older people, especially through the quality use of medicines. Through his teaching experience in Tasmanian and Western Australian universities, he is an accomplished educator, particularly within consultant pharmacy practice.
